| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003793 | American Journal of Ophthalmology | 2010 | 7 Pages |
Abstract
Our results indicate that anticoagulants and antiplatelet agents are strongly associated with the development of large subretinal hemorrhages in AMD patients. Moreover, arterial hypertension is a strong risk factor for large subretinal hemorrhages in AMD patients receiving anticoagulants or antiplatelet agents. Physicians should be aware of an increased risk of extensive subretinal hemorrhage in AMD patients when deciding on the initiation and duration of anticoagulant and antiplatelet therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Claudia Kuhli-Hattenbach, Ina Barbara Fischer, Rainer Schalnus, Lars-Olof Hattenbach,